Intra-Cellular Therapies, Inc.

ROYAL BANK OF CANADA

Report date

3/31/2025

Quarter

2025 Q1

Filed

11/21/2025

Shares

240,601

Value ($000)

31,740

Weight

0.0%

2019 Q4 - 2025 Q1 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q1	11/21/2025	31,740	0.0%	240,601	3/31/2025
2024 Q4	2/14/2025	13,733	0.0%	164,426	12/31/2024
2024 Q3	11/14/2024	9,957	0.0%	136,068	9/30/2024
2024 Q2	11/6/2024	2,783	0.0%	40,634	6/30/2024
2024 Q1	11/5/2024	2,630	0.0%	38,010	3/31/2024
2023 Q4	2/14/2024	4,832	0.0%	67,463	12/31/2023
2023 Q3	11/14/2023	2,547	0.0%	48,896	9/30/2023
2023 Q2	8/14/2023	4,129	0.0%	65,216	6/30/2023
2023 Q1	5/15/2023	2,964	0.0%	54,749	3/31/2023
2022 Q4	2/14/2023	2,950	0.0%	55,746	12/31/2022
2022 Q3	11/14/2022	2,043	0.0%	43,911	9/30/2022
2022 Q2	8/15/2022	1,082	0.0%	18,944	6/30/2022
2022 Q1	5/16/2022	1,372	0.0%	22,426	3/31/2022
2021 Q4	2/14/2022	1,906	0.0%	36,422	12/31/2021
2021 Q3	11/15/2021	1,109	0.0%	29,751	9/30/2021
2021 Q2	8/16/2021	793	0.0%	19,419	6/30/2021
2021 Q1	7/20/2021	472	0.0%	13,927	3/31/2021
2020 Q4	2/16/2021	872	0.0%	27,430	12/31/2020
2020 Q3	11/16/2020	719	0.0%	28,000	9/30/2020
2020 Q2	8/14/2020	125	0.0%	4,891	6/30/2020
2020 Q1	6/16/2020	111	0.0%	7,227	3/31/2020
2019 Q4	2/14/2020	275	0.0%	8,001	12/31/2019